0.994 USD
+0.02 (+2.47%)
0.96 USD
-0.03 (-3.42%)
ChartMill assigns a Buy % Consensus number of 83% to ESLA. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 16.32. This target is 1541.85% above the current price.
- ESLA was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about ESLA.
- In the previous month the buy percentage consensus was at a similar level.
- ESLA was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-03 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-08-12 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-06-03 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-05-29 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-02-21 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-02-18 | D. Boral Capital | Initiate | Buy |
ESTRELLA IMMUNOPHARMA INC / ESLA FAQ
What is the average price target for ESTRELLA IMMUNOPHARMA INC (ESLA) stock?
7 analysts have analysed ESLA and the average price target is 16.32 USD. This implies a price increase of 1541.85% is expected in the next year compared to the current price of 0.994.
Can you provide the consensus rating for ESTRELLA IMMUNOPHARMA INC stock?
The consensus rating for ESTRELLA IMMUNOPHARMA INC (ESLA) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.